Table 5.
Comparison of test parameters in the three groups.
| KDCB T0 | KDCB T1 | p-Value | KD T0 | KD T1 | p-Value | CB T0 | CB T1 | p-Value | |
|---|---|---|---|---|---|---|---|---|---|
| EuroQ_tot | 45.14 [11.98] | 35 [16.41] | 0.141 | 63.63 [38.65] | 75.71 [31.42] | 0.729 | 46.83 [33.2] | 56.67 [27.51] | 0.067 |
| FAS | 12.51 [5.88] | 8.63 [6.06] | 0.049 * | 16.88 [6.71] | 16.44 [6.32] | 0.860 | 10.9 [7.25] | 15.2 [2.11] | 0.155 |
| FIQR_tot | 41.43 [24.52] | 31.33 [21.42] | 0.032 * | 66.5 [42.14] | 64.52 [40.32] | 0.730 | 51.06 [36.26] | 66.39 [23.59] | 0.138 |
| FSS | 12.29 [8.42] | 9.63 [7.82] | 0.119 | 16.38 [8.6] | 16 [5.86] | 0.643 | 12.17 [9.41] | 15.83 [8.13] | 0.175 |
| DERS tot | 81.14 [22.45] | 76.63 [24.77] | 0.408 | 84.38 [29.13] | 79.71 [25.34] | 0.250 | 70.67 [16.27] | 67.83 [13.36] | 0.586 |
| YFAS level of FA | 0.86 [1.46] | 0.38 [1.06] | 0.356 | 0.5 [1.07] | 1.14 [1.35] | 0.280 | 0.17 [0.41] | 0.67 [1.21] | 0.363 |
EuroQ_tot, European Quality of Life total score; FAS, fibromyalgia assessment status; FIQR_tot, revised fibromyalgia impact questionnaire total score; FSS, fibromyalgia severity scale; DERS, difficulties in emotional regulation scale; YFAS, Yale food addiction scale; FA, food addiction; KDCB, ketogenic diet and carboxytherapy group; KD, ketogenic diet group; CB, carboxytherapy group; T0, baseline; T1, after ten weeks. Standard deviation in square brackets. Statistical significance was attributed as * p < 0.05.